Sheepwolf alone is quite capable of taking OTCs through the roof. I still remember what he did with nfuse.
We have all there is needed to uplist and approve this.
- Nader, left and right countering offers for non-delutive finances.
- RP, exchanged for all stock included all his patents and years of cancer research, to have a piece of the pie.
- Blockbuster product and the test patent.
- Samsung CMO
- SheepWolf
- AF on board with approval. Disagreed last time with 2020 revenue, as he didn't have the whole updated picture (test + compassionate use). With a bit lubricant he is fully on board.